Beyond Dopamine: Precision Pain Medicine Requires Phenotyping and Team Science, Not Just New Targets
International Journal of Spine Surgery · 2026-04 · 20 (2) · 218-219
DOI: 10.14444/8875 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Spine Surgery, online erschienen am 13.04.2026. Verfasst von Yenisel Cruz-Almeida. Beteiligte Einrichtung: Departments of Community Dentistry and Behavioral Science and Neuroscience, University of Florida, Gainesville, FL, USA cryeni@ufl.edu. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Departments of Community Dentistry and Behavioral Science and Neuroscience, University of Florida, Gainesville, FL, USA cryeni@ufl.edu.
- Pain Research and Intervention Center of Excellence, University of Florida, Gainesville, FL, USA.
Zitieren
APA
Cruz-Almeida, Y. (2026). Beyond Dopamine: Precision Pain Medicine Requires Phenotyping and Team Science, Not Just New Targets. International Journal of Spine Surgery, 20(2), 218-219. https://doi.org/10.14444/8875
Vancouver
Cruz-Almeida Y. Beyond Dopamine: Precision Pain Medicine Requires Phenotyping and Team Science, Not Just New Targets. International Journal of Spine Surgery. 2026;20(2):218-219. doi:10.14444/8875
BibTeX
@article{CruzAlmeida2026,
author = {Cruz-Almeida, Yenisel},
title = {Beyond Dopamine: Precision Pain Medicine Requires Phenotyping and Team Science, Not Just New Targets},
journal = {International Journal of Spine Surgery},
year = {2026},
volume = {20},
number = {2},
pages = {218--219},
doi = {10.14444/8875}
}
EUVIMED